Trial Design, Treatment Options Spotlighted in Xylazine Conference - MedPageToday

Clinical trials need to include more active users, researcher says

Longer observation periods following treatment and safety considerations for chronic and frequent users are among the many research issues about xylazine-laced fentanyl that need addressing, Rachel Wightman, MD, said at a meeting on mitigating risks from human xylazine exposure sponsored by the Reagan-Udall Foundation.

Read more